This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Kyoto University. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Osaka, JP (2016)
- Kyoto, JP (2022)
Company Filing History:
Years Active: 2016-2022
Title: Keizo Tomonaga: Innovator in Viral Vector Technology
Introduction
Keizo Tomonaga is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of viral vector technology, particularly in the context of gene introduction techniques. His work has implications for the treatment and prevention of various neurological diseases.
Latest Patents
Tomonaga holds 2 patents, with his latest inventions focusing on the Borna viral vector. One of his patents, titled "Borna viral vector and use thereof," discloses a viral vector that includes a cDNA of a recombinant viral RNA. This vector comprises a disrupted G gene of the Borna disease viral genome and an inserted G gene of an avian bornaviral genome. The invention is designed to be used as a gene introduction technique that does not affect the host chromosome, making it suitable for applications in neuroscience and the treatment of brain diseases.
Career Highlights
Keizo Tomonaga is affiliated with Kyoto University, where he conducts his research and development in viral vector technology. His innovative approaches have positioned him as a key figure in the field, contributing to advancements that could revolutionize treatments for neurological conditions.
Collaborations
Tomonaga has collaborated with notable colleagues, including Takuji Daito and Tomoyuki Honda. These partnerships have enhanced the scope and impact of his research, fostering a collaborative environment that encourages innovation.
Conclusion
Keizo Tomonaga's work in viral vector technology exemplifies the potential of innovative approaches to address complex medical challenges. His contributions continue to pave the way for advancements in the treatment of neurological diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
